China SFDA approves Veridex’s CellSearch test for women with metastatic breast cancer
Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch circulating tumor cell (CTC) test as an in vitro diagnostic for women with metastatic breast cancer.